Impax Laboratories Inc (NASDAQ:IPXL)

19.90
Delayed Data
As of Apr 20
 -0.30 / -1.49%
Today’s Change
12.50
Today|||52-Week Range
25.70
+19.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line57.4M39.0M-472.0M-469.3M
 
 
 
 
 
Depreciation34.0M68.6M88.3M109.4M
 
 
 
 
 
Total Other Cash Flow29.5M64.0M588.1M380.3M
 
 
 
 
 
Funds From Operations109.0M142.1M77.0M95.3M
 
 
 
 
 
Funds From/For Other Operating Expenses76.2M70.2M2.4M11.1M
 
 
 
 
 
Net Cash Flow - Operating Activities32.8M71.9M74.6M84.2M
 
 
 
 
 
 
InvestingIncrease In Investments-366.1M0.000.000.00
 
 
Decrease In Investments395.4M200.1M0.000.00
 
 
 
Capital Expenditures-29.9M-25.2M-49.4M-26.7M
 
 
 
 
 
Fixed Asset Disposal--59.5M1.4M9.1M
 
 
 
 
Net Assets From Acquisitions ---691.3M-585.8M-121.0K
 
 
 
 
Other Investing - Uses-3.0M-4.8M-4.8M-4.8M
 
 
 
 
 
Other Investing - Sources----15.0M12.9M
 
 
 
Net Cash Flow Investing-16.6M-467.5M-627.1M-9.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00--0.00--
Long Term Borrowings0.00998.1M388.1M-818.0K
 
 
 
 
Long Term Debt Reduction0.00-435.0M-5.0M-70.0M
 
 
 
 
Net Proceeds Stock Sale11.1M99.8M9.2M1.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00----0.00--
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing3.3M5.5M----
 
 
 
Other Uses - Financing--147.0M589.0K4.2M
 
 
 
 
Net Cash Flow - Financing14.4M521.4M391.8M-73.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-369.0K-298.0K494.0K773.0K
 
 
 
 
 
 
Net Change In Cash30.6M125.8M-160.7M872.0K